Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Stocks | 94.360 | 94.360 | 0.000 |
Bonds | 6.220 | 6.220 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 22.740 | 21.900 |
Price to Book | 3.504 | 4.027 |
Price to Sales | 2.169 | 2.283 |
Price to Cash Flow | 17.276 | 17.069 |
Dividend Yield | 0.961 | 1.335 |
5 Years Earnings Growth | 13.797 | 11.268 |
Number of long holdings: 80
Number of short holdings: 9
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly and Co | - | 5.32 | - | - | |
UnitedHealth Group Inc | - | 4.93 | - | - | |
Merck & Co Inc | - | 3.98 | - | - | |
NOVARTIS AG-NOM | - | 3.87 | - | - | |
Novo Nordisk B | DK0062498333 | 3.05 | 910.0 | +0.01% | |
Medincell | FR0004065605 | 2.95 | 15.20 | +1.33% | |
Thermo Fisher Scientific Inc | - | 2.65 | - | - | |
Boston Scientific Corp | - | 2.60 | - | - | |
UCB | BE0003739530 | 2.46 | 120.25 | -1.47% | |
Becton Dickinson & Co | - | 2.41 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pluvalca Disruptive Opportunities A | 137.86M | -2.89 | -13.03 | - | ||
Pluvalca France Small Caps A | 118.85M | 0.02 | -1.29 | 5.05 | ||
Pluvalca Initiatives PME A | 111.18M | -3.64 | -6.55 | 7.51 | ||
Pluvalca Allcaps A | 72.94M | 5.76 | 4.18 | 6.20 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review